Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Cempra Inc.'s Solithromycin (CEM-101) Demonstrates In Vitro Activity Against Antibiotic-Resistant Neisseria Gonorrhoeae Isolates
Cempra Inc.'s Solithromycin (CEM-101) Demonstrates In Vitro Activity Against Antibiotic-Resistant Neisseria Gonorrhoeae Isolates
Cempra Inc.'s Solithromycin (CEM-101) Demonstrates In Vitro Activity Against Antibiotic-Resistant Neisseria Gonorrhoeae Isolates
Submitted by
admin
on March 31, 2012 - 11:58am
Source:
Yahoo/PR NewsWire
News Tags:
Cempra
Solithromycin
Headline:
Cempra Inc.'s Solithromycin (CEM-101) Demonstrates In Vitro Activity Against Antibiotic-Resistant Neisseria Gonorrhoeae Isolates
Do Not Allow Advertisers to Use My Personal information
